Curcumin-artemisinin combination therapy for malaria
- PMID: 16641461
- PMCID: PMC1472230
- DOI: 10.1128/AAC.50.5.1859-1860.2006
Curcumin-artemisinin combination therapy for malaria
Abstract
Artemisinin and curcumin show an additive interaction in killing Plasmodium falciparum in culture. In vivo, 3 oral doses of curcumin following a single injection of alpha,beta-arteether to Plasmodium berghei-infected mice are able to prevent recrudescence due to alpha,beta-arteether monotherapy and ensure almost 100% survival of the animals.
Figures
References
-
- Cheng, A. L., J. K. Hsu, M. Lin, Y. F. Hsu, T. S. Ho, J. Y. Shen, J. T. Ko, B. R. Lin, W. Lin, H. S. Ming-Shiang, et al. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high risk or premalignant lesion. Anticancer Res. 21:2895-2900. - PubMed
-
- International Artemisinin Study Group. 2004. Artesunate combination for treatment of malaria: meta-analysis. Lancet 363:9-17. - PubMed
-
- Jambou, R., E. Legrand, M. Niang, N. Khim, P. Lim, B. Volney, M. T. Ekala, C. Bouchier, P. Esterre, T. Fandeur, and O. Mercereau-Puijalon. 2005. Resistance of Plasmodium falciparum field isolates to in vitro artemeether and point mutations of the SERCA-type PfATPase 6. Lancet 366:1960-1963. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical